Persistent Disease Activity Remains a Burden for Patients with Systemic Lupus Erythematosus

Abstract

Higher SLEDAI-2K at study entry was the single major independent predictor of higher SLEDAI-2K over time, reflecting frequent persistence of active disease, even in patients with longstanding disease. This highlights gaps in the optimal treatment of SLE.